Modern management of MS targets No Evidence of Disease Activity (NEDA): no clinical relapses, no magnetic resonance imaging (MRI) disease activity and no disability worsening. While MRI is the principal tool available to neurologists…
Continue Reading
Children’s Mercy Hospital in Kansas City has achieved a breakthrough in pediatric genomics by developing a process for conducting whole-genome sequencing tests within clinical settings. Dr. Tomi Pastinen, director of its Genomic Medicine Center,…
Continue Reading
Andre Esteva, Founder and CEO of ArteraAI
In recent years, the rapid advancement of artificial intelligence (AI) has created a wave of excitement and anticipation within the healthcare industry. AI has the potential to revolutionize…
Continue Reading
Digital health technologies (DHTs) enable remote data collection, support a patient-centric approach to drug development, and provide real-time data in real-world settings. With increasing use of DHTs in clinical care and development, we expect…
Continue Reading
Virtual care company TytoCare on Wednesday received clearance from the Food and Drug Administration for its wheeze detection algorithm, allowing the company to begin commercializing the product in the U.S.
TytoCare is headquartered in New…
Clinicians are using artificial intelligence (AI) to enhance clinical decision-making and improve patient outcomes when it comes to cerebral aneurysms. Aneurysms are difficult to monitor due to their…
Continue Reading
Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives…
Continue Reading
The following is a guest article by Josh Miller, Co-Founder & CEO at Gradient Health.
As a global society, we have never spent more on healthcare. We have never been more informed. We’ve never been…
